Perhaps that is being left to the Customers as not to steal their thunder.
I believe that UNS should be doing everything possible to talk up their accomplishments short of trampling on their downstream customers.
Short term they need to close the AbbVie deal and seek an increase in the debt facility to ensure production ramp. That would take a CR off the table and put a floor under the SP. They don't need to do another dilutive CR when they can leverage those contracts.
UNS Price at posting:
44.0¢ Sentiment: Buy Disclosure: Held